RECENT ARTICLES
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
Article TextGut microbiotaOriginal researchFaecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trialObjective Type 1 diabetes (T1D) is characterised by islet autoimmunity and beta cell destruction. A gut microbiota–immunological interplay is involved in the pathophysiology of T1D. We studied microbiota-mediated effects on disease progression in patients with type 1 diabetes using faecal microbiota transplantation (FMT).Design Patients with recent-onset (<6 weeks) T1D (18–30 years of age) were randomised into two groups to...…Article TextGut microbiotaOriginal researchFaecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trialObjective Type 1 diabetes (T1D) is characterised by islet autoimmunity and beta cell destruction. A gut microbiota–immunological interplay is involved in the pathophysiology of T1D. We studied microbiota-mediated effects on disease progression in patients with type 1 diabetes using faecal microbiota transplantation (FMT).Design Patients with recent-onset (<6 weeks) T1D (18–30 years of age) were randomised into two groups to...WW…
- Total 1 items
- 1